Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Testicular Neoplasms

fluorodeoxyglucose f18 has been researched along with Testicular Neoplasms in 120 studies

Research

Studies (120)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (7.50)18.2507
2000's47 (39.17)29.6817
2010's45 (37.50)24.3611
2020's19 (15.83)2.80

Authors

AuthorsStudies
Hsieh, TC; Kao, CH; Sun, SS; Wu, YC1
Garland-Kledzik, M; Hamilton, O; Likar, C; Thomay, A; Williams, A1
Abraham, C; Barthelemy, P; Bompas, E; Chevreau, C; Culine, S; Fizazi, K; Fléchon, A; Geoffrois, L; Gravis, G; Grimaldi, S; Gross-Goupil, M; Helissey, C; Lacourtoisie, SA; Ladoire, S; Laguerre, B; Loriot, Y; Mahammedi, H; Massard, C; Texier, M; Thiery-Vuillemin, A1
Conduit, C; Goad, J; Hofman, MS; Koh, TT; Lawrentschuk, N; Lewin, JH; Tai, KH; Toner, GC; Tran, B1
Bot, F; Grootemaat, M; Roshani, H; Sampimon, D; Tjiam, I1
Araz, M; Gulpinar, B; Kucuk, NO; Nak, D; Ozkan, E; Soydal, C; Urun, Y1
Eura, R; Fujii, K; Higashi, Y; Hirohata, Y; Kanekura, T; Nakagawa, M; Okubo, A; Osako, Y; Tada, KI; Yoshino, H1
Cheng, X; Hou, G; Jiang, Y1
Mottet, N; Tremeau, L1
Al-Kandari, F; Ghanem, M; Marafi, F; Rasheed, R; Usmani, S1
Aoyama, Y; Fukuzawa, T; Hashimoto, J; Ichikawa, T; Ikoma, H; Kajiwara, H; Kazama, T; Kodama, E; Kuroki, T; Mabuchi, T; Mikami, T; Nagafuji, Y; Nagao, R; Sekiguchi, Y1
Fanti, S; Farolfi, A; Koschel, S; Murphy, DG1
Ambrosini, V; Calabrò, D; Telo, S1
Aydos, U; Özet, A; Özgür Akdemir, Ü; Tahtaci, G1
Sharma, P1
Alessi, A; Bandini, M; Calareso, G; Colecchia, M; Farè, E; Giannatempo, P; Marandino, L; Necchi, A; Padovano, B; Raggi, D; Serafini, G1
Jiang, G; Ou, L; Wu, J; Zhang, C1
Agrawal, A; Bakshi, G; Carlton, J; Joshi, A; Karmakar, S; Krishnatry, R; Menon, S; Murthy, V; Noronha, V; Pal, M; Prabhash, K; Prakash, G; Rangarajan, V1
Aydin, M; Peker, AA; Toprak, H; Yasin, AI1
Cárdenas-Perilla, R1
Kang, S; Park, I1
Han, EJ; Lee, J; O, JH; Park, G1
Barras, JL; Burruni, R; Maged, Z; Schaefer, N; Van Der Gucht, A1
Eiber, M; Gschwend, JE; Horn, T; Maurer, T; Rauscher, I; Weber, WA1
Bokemeyer, C; Fisch, M; Hartmann, M; Klutmann, S; Meyer, CP; Oechsle, K; Oing, C; Schriefer, P1
Gorin, MA; Joice, GA; Pierorazio, PM; Rowe, SP1
Dong, C; Jiang, Y; Lü, X; Wang, Y; Xiao, Z; Xu, P1
Akhurst, T; Hicks, RJ; Hofman, MS; Hung, TJ; Iravani, A; Lawrentschuk, N; Lewin, J; McLean, L; Mitchell, C; Murphy, DG; Pascoe, C; Singh, D; Zidan, L1
Colling, CW; Robinson, RA; Vaena, DA; Wudhikarn, K1
Allegri, V; Ambrosini, V; Berselli, A; Cricca, A; Domenico, R; Fanti, S; Martoni, A; Nanni, C; Nicolini, S; Rubello, D; Zucchini, G1
Borbély, K; Géczi, L; Kásler, M1
Bilen, MA; Guo, CC; Hariri, H; Kuban, DA; Leon, C; Pisters, LL; Tu, SM1
Li, MM; Li, YY; Liu, L; Ma, XL; Zhang, BL; Zhao, JY1
Deroose, CM; Gheysens, O; Lips, N; Moerman, P; Peetermans, WE; Schöffski, P; Slabbaert, K; Vancleynenbreugel, B1
Annunziata, S; Bertagna, F; Caldarella, C; Giovanella, L; Sadeghi, R; Treglia, G1
Chen, J; Geng, D; Sun, D; Yu, R; Zhang, L1
Lin, M; Lin, P; Rosenfeld, D; Sidhu, P; Son, H1
Liepe, K1
Albers, P; Decoene, J; Winter, C1
Chua, S; Cook, GJ; Dearnaley, DP; Horwich, A; Huddart, RA; Sohaib, A1
Batra, S; Karanth, SS; Sharma, D; Vaid, AK1
Kawase, T; Kubota, K; Naka, G; Sakashita, B; Takeda, Y1
Bouchelouche, K; Choyke, PL1
Richie, JP1
Hsieh, TC; Kao, CH; Lin, CC; Sun, SS; Wu, YC1
Alessi, A; Crippa, F; Giannatempo, P; Mariani, L; Miceli, R; Necchi, A; Nicolai, N; Padovano, B; Raggi, D; Salvioni, R; Serafini, G; Tana, S1
Hashizume, A; Kawai, M; Kishida, T; Mizuno, N1
Chang, SS1
Bares, R; Bokemeyer, C; Brenner, W; de Wit, M; Franzius, C; Hartmann, M; Heicappell, R; Kliesch, S; Krege, S; Mueller, S; Oechsle, K; Venz, S; Weissbach, L1
Aide, N; Allouche, S; Batalla, A; Briand, M; Dutoit, S; Gauduchon, P; Labiche, A; Montravers, F; Nataf, V; Ngo-Van Do, A; Poulain, L; Talbot, JN1
Badler, RL; Katz, DS; Mahboob, S; Santoro, MS; Scalcione, LR; Yung, EY1
Biron, P; Cimarelli, S; Deshayes, E; Desuzinges, C; Giammarile, F; Mognetti, T; Rivoire, M1
Lee, G; Lee, JH; Lee, WA1
de Jong, JS; Hoekstra, HJ; Lemstra, CL; Mulder, NH; Paans, AM; Slart, RH; van Ginkel, RJ1
Aide, N; Bohn, P; Briand, M; Carreiras, F; Chasle, J; Deslandes, E; Dutoit, S; Lasnon, C; Modzelewski, R; Poulain, L; Rouvet, J; Vela, A; Vera, P1
Cathomas, R; Mueller, J; Putora, PM; Schmidt, F; Stallmach, T1
Jentzmik, F; Müller, J; Schrader, AJ; Schrader, M1
Becherer, A1
Akbulut, Z; Asil, E; Atmaca, AF; Balbay, MD; Caglayan, A; Canda, AE1
Brillouet, S; Bujan, L; Courbon, F; Delauney, B; Dierickx, LO; Filleron, T; Huyghe, E; Montagut, J; Nogueira, D; Plante, P; Zerdoud, S1
Dang, CJ; Li, YJ; Zhan, FH1
Newey, CR; Sarwal, A; Wu, G1
Abrahámová, J; Büchler, T; Fencl, P; Simonová, K1
Abrahamova, J; Buchler, T; Fencl, P; Jarkovsky, J; Simonova, K1
Chmielowska, E; Chłosta, P; Drewa, T; Jasiński, M; Jóźwicki, W; Kamecki, K; Kraśnicki, K; Małkowski, B; Mikołajczak, W; Petrus, A; Pietrzak, T; Siekiera, J; Wronczewski, A1
Kocáková, I; Krejčí, E; Rehák, Z; Szturz, P1
Ferrari, C; Losco, M; Niccoli Asabella, A; Nicoletti, A; Rubini, D; Rubini, G1
Hsieh, TC; Kao, CH; Shen, YY; Yen, KY1
Biersack, HJ; Matthies, A; Reinhardt, MJ1
Agoston, P; Bodrogi, I; Esik, O; Lengyel, E; Lengyel, Z; Márián, T; Sáfrány, G; Székely, J; Trón, L; Vönöczky, K1
Damgaard, K; Daugaard, G; Eigtved, A; Højgaard, L; Lassen, U; Rørth, M1
Bourguet, P1
Aigner, RM; Krippl, P; Samonigg, H; Schwarz, T; Wolf, G1
Huddart, RA1
Nguyen, BD1
Granov, AM; Kostenikov, NA; Ryzhkova, DV; Savello, VE; Stanzhevskiĭ, AA; Tiushin, LA; Tlostanova, MS1
Bares, R; Bokemeyer, C; Claussen, CD; Dohmen, BM; Kollmannsberger, C; Oechsle, K; Pfannenberg, AC; Vontheim, R1
Becherer, A; Bokemeyer, C; De Santis, M; Dittrich, C; Dohmen, BM; Kletter, K; Lang, A; Oechsle, K; Pont, J; Sellner, F; Stoiber, F1
Baillet, G; Moretti, JL; Tamgac, F; Tofighi, M; Weinmann, P1
Lenzo, NP; Moschilla, G; Patrikeos, A1
Alavi, A; Kumar, R; Zhuang, H1
Lincke, T; Sabri, O; Scheid, R; Voltz, R; von Cramon, DY1
Schöder, H; Weng, LJ1
Becherer, A; Bokemeyer, C; De Santis, M; Dittrich, C; Dohmen, BM; Dudczak, R; Karanikas, G; Kletter, K; Pont, J; Szabó, M1
De Giorgi, U; Fiorentini, G; Marangolo, M; Pupi, A; Rosti, G1
Arzumanov, AA; Granov, AM; Karelin, MI; Kostenikov, NA; Ryzhkova, DV; Shkol'nik, MI; Stanzhevskiĭ, AA; Tlostanova, MS1
Cheng, DW; Cooper, DL; Kuo, PH1
Gilligan, T1
Fujimoto, K; Hirao, Y; Hirayama, A; Matsushita, C; Miyake, M; Nonomura, A; Takashima, K; Tanaka, M1
Bridges, B; Hussain, A1
Castle, J; Dalmau, J; Newman-Toker, DE; Sakonju, A1
Davison, JM; Koff, SG; Montilla-Soler, JL; Sterbis, JR1
Juergens, KU; Kliesch, S; Stegger, L; Weckesser, M; Wormanns, D1
Ali, I; Bottger, B; Gupta, SM; Johns, W1
Bourguet, P; Montravers, F; Planchamp, F; Vincendeau, S1
Cerny, T; Gillessen, S; Joerger, M; Klaeser, B; Kluckert, T; von Rohr, L1
Daugaard, G; Hain, SF; Harland, SJ; Huddart, RA; Joffe, JK; Kirk, SJ; Logue, J; MacKewn, JE; Mead, GM; O'Doherty, MJ; Padhani, A; Rustin, GJ; Stenning, SP; Vasey, P1
Laing, R; Nam, H; Smith, S1
Bouchelouche, K; Oehr, P1
Amthauer, H; Bares, R; Bokemeyer, C; Brenner, W; Cremerius, U; de Wit, M; Dohmen, BM; Franzius, C; Geworski, L; Hartmann, M; Heicappell, R; Hellwig, D; Kliesch, S; Kotzerke, J; Lehmann, J; Schirrmeister, H; Schlemmer, M; Tatsch, K1
Cronin, BF; Flower, MA; Horwich, A; McCready, VR; Ott, RJ; Pratt, BE; Wilson, CB; Young, HE1
Bachor, R; Gropengiesser, F; Hautmann, RE; Kocher, F; Reske, SN1
Larcos, G; Maisey, MN1
Ackermann, R; Gerharz, CD; Müller-Gärtner, HW; Müller-Mattheis, VG; Reinhardt, MJ; Vosberg, HR1
Elomaa, I; Joensuu, H; Leskinen, S; Minn, H; Nuutinen, JM; Salminen, E; Söderström, KO; Solin, O; Varpula, M1
Adam, G; Buell, U; Cremerius, U; Effert, PJ; Jakse, G; Sabri, O; Wagenknecht, G; Zimmy, M1
Conti, PS; Muggia, FM1
Ackermann, R; Fürst, G; Gerharz, CD; Müller-Gärtner, HW; Müller-Mattheis, V; Reinhardt, M; Vosberg, H1
Borchers, H; Buell, U; Cremerius, U; Günther, RW; Jakse, G; Wildberger, JE; Zimny, M1
Hain, SF; Huddart, RA; Leslie, MD; O'Doherty, MJ; Partridge, SE; Timothy, AR1
Hain, SF; Harper, PG; Huddart, RA; Leslie, MD; O'Doherty, MJ; Timothy, AR1
Foehrenbach, H; Lumbroso, J; Maszelin, P; Merlet, P; Syrota, A; Theodore, C1
Becherer, A; Bokemeyer, C; De Santis, M; Dittrich, C; Dohmen, BM; Kletter, K; Oechsle, K; Pont, J; Stoiber, F1
Avril, N; Breul, J; Hartung, R; Hofer, C; Kübler, H1
Harper, PG; Karapetis, CS; Strickland, AH; van der Walt, JD; Yip, D1
Bares, R; Bokemeyer, C; Claussen, CD; Dohmen, BM; Kanz, L; Kollmannsberger, C; Oechsle, K; Pfannenberg, A1
Beuthien-Baumann, B; Burchert, W; Franke, WG; Hakenberg, OW; Kropp, J; Manseck, A; Tiepolt, C; Tsatalpas, P; Wirth, MP1
De Geus-Oei, LF; Kiemeney, LA; Oyen, WJ; Spermon, JR; Witjes, JA1
Arocena, J; Berian, JM; Fernandez, JM; Gimenez, M; Lopez, J; Robles, JE; Rosell, D; Sanchez, D; Sanz, G; Zudaire, JJ1
Bodrogi, I; Esik, O; Galuska, L; Géczi, L; Kálvin, B; Márián, T; Szakáll, S; Trón, L1

Reviews

22 review(s) available for fluorodeoxyglucose f18 and Testicular Neoplasms

ArticleYear
[Management of residual masses of testis germ cell tumors].
    Bulletin du cancer, 2020, Volume: 107, Issue:2

    Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Male; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Radiopharmaceuticals; Seminoma; Testicular Neoplasms

2020
PET imaging in urology: a rapidly growing successful collaboration.
    Current opinion in urology, 2020, Volume: 30, Issue:5

    Topics: Antigens, Surface; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Kidney Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Urology

2020
PET imaging in testicular tumours.
    Current opinion in urology, 2020, Volume: 30, Issue:5

    Topics: Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms

2020
Positron-emission tomography imaging in urological oncology: Current aspects and developments.
    International journal of urology : official journal of the Japanese Urological Association, 2018, Volume: 25, Issue:11

    Topics: Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Medical Oncology; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Urinary Bladder Neoplasms

2018
[Positron emission tomography in germ cell tumors in men : Possibilities and limitations].
    Der Urologe. Ausg. A, 2019, Volume: 58, Issue:4

    Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms

2019
Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases.
    Current urology reports, 2018, Nov-09, Volume: 19, Issue:12

    Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Molecular Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Space; Seminoma; Testicular Neoplasms

2018
[18F-FDG PET/CT features on paraganglioma of testis with multiple lymph node and lung metastasis: A case report and literature review].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2018, Oct-28, Volume: 43, Issue:10

    Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Paraganglioma; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Testicular Neoplasms; Testis

2018
[Why is PET/CT essential in urooncology?].
    Magyar onkologia, 2013, Volume: 57, Issue:4

    Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms; Urogenital Neoplasms

2013
Positive FDG-PET/CT scans of a residual seminoma after chemotherapy and radiotherapy: case report and review of the literature.
    Clinical genitourinary cancer, 2014, Volume: 12, Issue:4

    Topics: Adult; Chemoradiotherapy; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed

2014
Diagnostic accuracy of 18F-FDG-PET in patients with testicular cancer: a meta-analysis.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:8

    Topics: Area Under Curve; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasms, Germ Cell and Embryonal; Odds Ratio; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed

2014
Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the postchemotherapy management of patients with seminoma: systematic review and meta-analysis.
    BioMed research international, 2014, Volume: 2014

    Topics: Fluorodeoxyglucose F18; Humans; Male; Monitoring, Physiologic; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms

2014
PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.
    PET clinics, 2015, Volume: 10, Issue:3

    Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed; Urinary Bladder Neoplasms

2015
[Assessment of residual tumours after systemic treatment of metastatic seminoma: ¹⁸F-2-fluoro-2-deoxy-D-glucose positron emission tomography - meta-analysis of diagnostic value].
    Der Urologe. Ausg. A, 2011, Volume: 50, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Treatment Outcome; Young Adult

2011
PET-imaging in tumors of the reproductive trac.
    The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2002, Volume: 46, Issue:2

    Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Ovarian Neoplasms; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Tomography, Emission-Computed; Uterine Cervical Neoplasms

2002
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
    Bulletin du cancer, 2003, Volume: 90 Spec No

    Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urologic Neoplasms

2003
[The interest of 18FDG-PET in the management of testicular cancer].
    Presse medicale (Paris, France : 1983), 2004, Feb-28, Volume: 33, Issue:4

    Topics: Adolescent; Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Retrospective Studies; Seminoma; Testicular Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography

2004
PET in the management of urologic malignancies.
    Radiologic clinics of North America, 2004, Volume: 42, Issue:6

    Topics: Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Urogenital Neoplasms

2004
Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis.
    Archives of neurology, 2004, Volume: 61, Issue:11

    Topics: Adult; Electroencephalography; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Limbic Encephalitis; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Temporal Lobe; Teratoma; Testicular Neoplasms

2004
FDG-PET in the management of germ cell tumor.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16 Suppl 4

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Predictive Value of Tests; Retroperitoneal Neoplasms; Testicular Neoplasms; Treatment Outcome

2005
Testicular germ cell tumors.
    Current opinion in oncology, 2006, Volume: 18, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Fluorodeoxyglucose F18; Gene Expression Profiling; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasm Proteins; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Orchiectomy; Positron-Emission Tomography; Radiotherapy, Adjuvant; Risk Factors; Testicular Neoplasms; Treatment Outcome

2006
Recent developments in urologic oncology: positron emission tomography molecular imaging.
    Current opinion in oncology, 2008, Volume: 20, Issue:3

    Topics: Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm, Residual; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Testicular Neoplasms; Urinary Bladder Neoplasms

2008
Diagnosis and monitoring of urological tumors using positron emission tomography.
    European urology, 2001, Volume: 40, Issue:5

    Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urogenital Neoplasms

2001

Trials

12 trial(s) available for fluorodeoxyglucose f18 and Testicular Neoplasms

ArticleYear
The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    European urology, 2022, Volume: 82, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Treatment Outcome

2022
Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Aged; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Secondary Prevention; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting

2003
FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals.
    European journal of radiology, 2005, Volume: 54, Issue:2

    Topics: Abdomen; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiographic Image Enhancement; Radiography, Abdominal; Radiography, Thoracic; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Thorax; Tomography, Spiral Computed

2005
18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Jul-20, Volume: 25, Issue:21

    Topics: Adolescent; Adult; Biopsy, Needle; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Fluorodeoxyglucose F18; Germinoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Orchiectomy; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Risk Assessment; Salvage Therapy; Sensitivity and Specificity; Survival Analysis; Testicular Neoplasms

2007
[18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:9

    Topics: Adolescent; Adult; Fluorodeoxyglucose F18; Germany; Humans; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Risk Assessment; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed

2008
Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET.
    European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:8

    Topics: Adult; Deoxyglucose; Diagnostic Errors; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed

1997
Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?--Results of a study in 50 patients.
    Urology, 1999, Volume: 54, Issue:5

    Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Predictive Value of Tests; Radiopharmaceuticals; Testicular Neoplasms; Tomography, Emission-Computed

1999
Fluorodeoxyglucose PET in the initial staging of germ cell tumours.
    European journal of nuclear medicine, 2000, Volume: 27, Issue:5

    Topics: Adolescent; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Germinoma; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed

2000
Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
    British journal of cancer, 2000, Volume: 83, Issue:7

    Topics: Adolescent; Adult; alpha-Fetoproteins; Biomarkers, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Germinoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Seminoma; Sensitivity and Specificity; Teratoma; Testicular Neoplasms; Tomography, Emission-Computed

2000
[Fluorodeoxyglucose (FDO) positron emission tomography (PET) in testicular germ cell tumors in adults: preliminary French clinical evaluation, development of the technique and its clinical applications].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2000, Volume: 10, Issue:6

    Topics: Adult; Equipment Design; Fluorodeoxyglucose F18; France; Germinoma; Humans; Male; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed

2000
Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Sep-01, Volume: 19, Issue:17

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm, Residual; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed

2001
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET.
    British journal of cancer, 2002, Feb-12, Volume: 86, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Salvage Therapy; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Treatment Outcome

2002

Other Studies

86 other study(ies) available for fluorodeoxyglucose f18 and Testicular Neoplasms

ArticleYear
Rare "Burned-Out" Testicular Mixed Germ Cell Tumor on 18 F-FDG PET/CT.
    Clinical nuclear medicine, 2022, Sep-01, Volume: 47, Issue:9

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Germ Cell and Embryonal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Testicular Neoplasms; Young Adult

2022
"The Benefit Of Positron Emission Tomography/Computed Tomography In Stage I And Stage II Melanomas With High-Risk Decisiondx-Melanoma Scores".
    The American surgeon, 2022, Volume: 88, Issue:7

    Topics: Dichlorodiphenyl Dichloroethylene; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms

2022
Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up.
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2022, Oct-08, Volume: 22, Issue:1

    Topics: Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed

2022
Bilateral Adrenal and testicular Tumours; When a Simple Diagnosis Becomes Complicated.
    Urology, 2023, Volume: 175

    Topics: Aged; BCG Vaccine; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Testicular Neoplasms; Urinary Bladder Neoplasms

2023
18F-Flourodeoxy glucose PET-computed tomography in testicular carcinoma: diagnostic and prognostic value.
    Nuclear medicine communications, 2019, Volume: 40, Issue:12

    Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Survival Analysis; Testicular Neoplasms; Young Adult

2019
Acne vulgaris with false-positive signals on
    The Journal of dermatology, 2020, Volume: 47, Issue:1

    Topics: Acne Vulgaris; Endodermal Sinus Tumor; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Testicular Neoplasms; Young Adult

2020
Testicular Metastasis of Pancreatic Carcinoma on FDG-PET/CT.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:1

    Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Testicular Neoplasms

2020
Significance of 18F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting.
    Asian Pacific journal of cancer prevention : APJCP, 2020, Feb-01, Volume: 21, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Young Adult

2020
Cutaneous Metastases from Testicular Diffuse Large B-cell Malignant Lymphoma and Bowen Disease: 18F-FDG PET-CT Findings.
    The Tokai journal of experimental and clinical medicine, 2020, Jul-20, Volume: 45, Issue:2

    Topics: Bowen's Disease; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Radiopharmaceuticals; Skin Neoplasms; Testicular Neoplasms

2020
18F-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of 18F-FDG PET positivity and prognostic value of PET derived metabolic parameters.
    Nuclear medicine communications, 2020, Volume: 41, Issue:11

    Topics: Adult; Aged; Biomarkers, Tumor; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Survival Analysis; Testicular Neoplasms; Tumor Burden; Whole Body Imaging

2020
Adenocarcinoma of the Lung With Initial Presentation as Painful Testicular Metastasis: 18F-FDG PET/CT Findings in an Unusual Case.
    Clinical nuclear medicine, 2021, Apr-01, Volume: 46, Issue:4

    Topics: Adenocarcinoma of Lung; Cancer Pain; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Testicular Neoplasms

2021
Prognostic Role of Early Interim Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced Seminoma Undergoing Standard Treatment.
    Clinical genitourinary cancer, 2021, Volume: 19, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Seminoma; Testicular Neoplasms

2021
18F-FDG PET/CT Imaging of Testicular Myeloid Sarcoma in a Pediatric Patient.
    Clinical nuclear medicine, 2021, Volume: 46, Issue:1

    Topics: Child; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Sarcoma, Myeloid; Testicular Neoplasms

2021
Radiotherapy for Post-Chemotherapy Residual Mass in Advanced Seminoma: A Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Risk-adapted Approach.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2021, Volume: 33, Issue:7

    Topics: Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms

2021
Uncommon Testicular Germ Cell Tumor Thrombus in Azygos Vein Detected by FDG PET/CT.
    Clinical nuclear medicine, 2021, Jul-01, Volume: 46, Issue:7

    Topics: Adult; Azygos Vein; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Positron Emission Tomography Computed Tomography; Testicular Neoplasms; Thrombosis

2021
Malignant somatic transformation arising from teratoma in metastatic testicular germ cell tumor detected on
    Revista espanola de medicina nuclear e imagen molecular, 2022, Volume: 41 Suppl 1

    Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Teratoma; Testicular Neoplasms

2022
Distal appendicular skeletal involvement of diffuse large B-cell lymphoma on technetium-99m methylenediphosphonate bone scintigraphy and
    Journal of medical case reports, 2017, Apr-04, Volume: 11, Issue:1

    Topics: Aged; Bone Neoplasms; Diphosphonates; Fluorodeoxyglucose F18; Gingivitis; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Maxilla; Organotechnetium Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Skin Neoplasms; Testicular Neoplasms; Tooth Extraction; Treatment Outcome; Whole Body Imaging

2017
FDG PET/CT Image of Seminoma in Androgen Insensitivity Syndrome.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:8

    Topics: Androgen-Insensitivity Syndrome; Female; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Seminoma; Testicular Neoplasms; Young Adult

2017
Testicular Estrogen-Secreting Leydig Cell Tumor in 18F-FDG PET/CT: An Incidental Detection in a Patient Treated by Chemotherapy for Hodgkin Lymphoma.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:1

    Topics: Estrogens; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Incidental Findings; Leydig Cell Tumor; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Testicular Neoplasms

2018
The role of
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2019, May-29, Volume: 19, Issue:1

    Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Germ Cell and Embryonal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Testicular Neoplasms

2019
Solitary bony metastasis in seminoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jun-01, Volume: 31, Issue:16

    Topics: Biomarkers, Tumor; Bone Neoplasms; Chorionic Gonadotropin, beta Subunit, Human; Contrast Media; Fluorodeoxyglucose F18; Humans; Humerus; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Orchiectomy; Positron-Emission Tomography; Radiotherapy, Adjuvant; Rotator Cuff; Seminoma; Shoulder Impingement Syndrome; Testicular Neoplasms; Tomography, X-Ray Computed

2013
18F-FDG PET/CT impact on testicular tumours clinical management.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:4

    Topics: Adolescent; Adult; Aged; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed

2014
The more you look, the more you find: challenging results on FDG-PET CT in a patient with neurofibromatosis type I.
    BMC medical imaging, 2014, May-29, Volume: 14

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neurilemmoma; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed

2014
Primary Testicular Serous Papillary Carcinoma With Extensive Calcification on CT and FDG PET/CT.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:10

    Topics: Aged; Calcinosis; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed

2014
Testicular fluorine-18 fludeoxyglucose uptake on positron emission tomography CT in patients with lymphoma: clinical significance and management impact.
    The British journal of radiology, 2014, Volume: 87, Issue:1044

    Topics: Adult; Aged; Aged, 80 and over; Disease Management; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Testicular Neoplasms; Testis; Tomography, X-Ray Computed

2014
False-positive finding in FDG-PET in a patient with seminoma and sarcoidosis.
    Acta clinica Belgica, 2015, Volume: 70, Issue:2

    Topics: Adult; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Seminoma; Testicular Neoplasms

2015
False-positive fluorodeoxyglucose positron emission tomography results after chemotherapy in patients with metastatic seminoma.
    Urologic oncology, 2015, Volume: 33, Issue:1

    Topics: Adult; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Seminoma; Testicular Neoplasms

2015
The role of 18F-FDG PET/CT in the management of testicular cancers.
    Nuclear medicine communications, 2015, Volume: 36, Issue:7

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed

2015
Mediastinal germ cell tumour causing superior vena cava tumour thrombosis.
    BMJ case reports, 2015, Mar-25, Volume: 2015

    Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chest Pain; Cisplatin; Etoposide; Fluorodeoxyglucose F18; Heparin, Low-Molecular-Weight; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms; Treatment Outcome; Vena Cava, Superior; Venous Thromboembolism

2015
NUT Midline Carcinoma in Elderly Patients: Usefulness of 18F-FDG PET/CT for Treatment Assessment.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:9

    Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed

2015
Re: 18F-FDG PET/CT Impact on Testicular Tumours Clinical Management.
    The Journal of urology, 2015, Volume: 194, Issue:4

    Topics: Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed

2015
Asymptomatic Solitary Metastasis to the Testis From Prostate Carcinoma Detected by FDG PET/CT.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:1

    Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed

2016
Interim (18)F-Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Response to Cisplatin, Etoposide, and Bleomycin Chemotherapy for Metastatic Seminoma: Clinical Value and Future Directions.
    Clinical genitourinary cancer, 2016, Volume: 14, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tissue Distribution; Treatment Outcome; Tumor Burden

2016
[A Case of Metastatic Seminomatous Testicular Tumor with Complicated Diagnosis by FDG-PET].
    Hinyokika kiyo. Acta urologica Japonica, 2016, Volume: 62, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Treatment Outcome

2016
Re: PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.
    The Journal of urology, 2017, Volume: 197, Issue:1

    Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms

2017
[18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Dec-20, Volume: 26, Issue:36

    Topics: Adolescent; Adult; Biomarkers, Tumor; Cell Survival; Cisplatin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Retroperitoneal Neoplasms; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed

2008
Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory disease.
    European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Embryonal; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin A; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Testicular Neoplasms; Time Factors; Transplantation, Heterologous; Xenograft Model Antitumor Assays

2009
Primary testicular lymphoma involving the spermatic cord and gonadal vein.
    Clinical nuclear medicine, 2009, Volume: 34, Issue:4

    Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron-Emission Tomography; Radiopharmaceuticals; Spermatic Cord; Testicular Neoplasms; Testis; Tomography, X-Ray Computed; Veins

2009
F-18 FDG PET/CT imaging in a case of primary choriocarcinoma in the retroperitoneum.
    Clinical nuclear medicine, 2009, Volume: 34, Issue:7

    Topics: Adult; Choriocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Testicular Neoplasms; Tomography, X-Ray Computed

2009
F-18 FDG PET/CT imaging of a Leydig cell tumor.
    Clinical nuclear medicine, 2010, Volume: 35, Issue:3

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Leydig Cell Tumor; Male; Positron-Emission Tomography; Testicular Neoplasms; Tomography, X-Ray Computed

2010
FDG-PET probe-guided surgery for recurrent retroperitoneal testicular tumor recurrences.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2010, Volume: 36, Issue:11

    Topics: Adult; Dysgerminoma; Fluorodeoxyglucose F18; Gamma Rays; Humans; Male; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retroperitoneal Neoplasms; Testicular Neoplasms; Time Factors; Tomography, X-Ray Computed

2010
αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical study.
    European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:2

    Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Transformation, Neoplastic; Cisplatin; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Male; Molecular Imaging; Necrosis; Neoplasm, Residual; Rats; Teratoma; Testicular Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Tretinoin

2011
Have you ever heard of hibernoma? A rare but important pitfall in FDG-PET/CT.
    Nuklearmedizin. Nuclear medicine, 2010, Volume: 49, Issue:6

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Lipoma; Lymphatic Metastasis; Male; Orchiectomy; Positron-Emission Tomography; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome

2010
PET in testicular cancer.
    Methods in molecular biology (Clifton, N.J.), 2011, Volume: 727

    Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors; Testicular Neoplasms

2011
Is positron emission tomography reliable to predict post-chemotherapy retroperitoneal lymph node involvement in advanced germ cell tumors of the testis?
    Urology journal, 2011,Spring, Volume: 8, Issue:2

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retroperitoneal Space; Sensitivity and Specificity; Testicular Neoplasms; Young Adult

2011
Functional testicular evaluation using PET/CT with 18F-fluorodeoxyglucose.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:1

    Topics: Adolescent; Adult; Andrology; Biological Transport; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Sperm Count; Sperm Motility; Spermatozoa; Testicular Neoplasms; Testis; Tomography, X-Ray Computed; Young Adult

2012
FDG PET/CT of bilateral testicular lymphoma.
    Clinical nuclear medicine, 2012, Volume: 37, Issue:1

    Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Positron-Emission Tomography; Testicular Neoplasms; Tomography, X-Ray Computed

2012
Radiological correlate of ocular flutter in a case with paraneoplastic encephalitis.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2013, Volume: 23, Issue:2

    Topics: Cerebellar Ataxia; Diagnosis, Differential; Encephalitis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Ocular Motility Disorders; Paraneoplastic Syndromes, Nervous System; Paraneoplastic Syndromes, Ocular; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms

2013
[Positron emission tomography in the diagnosis and monitoring of patients with nonseminomatous germ cell tumours].
    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2011, Volume: 24, Issue:6

    Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms

2011
Clinical outcomes of patients with nonseminomatous germ cell tumours and negative postchemotherapy positron emission tomography.
    Cancer investigation, 2012, Volume: 30, Issue:6

    Topics: Adolescent; Adult; Disease-Free Survival; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Predictive Value of Tests; Teratoma; Testicular Neoplasms; Young Adult

2012
Can we rely on PET in the follow-up of advanced seminoma patients?
    Urologia internationalis, 2012, Volume: 88, Issue:4

    Topics: Antineoplastic Agents; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm, Residual; Poland; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Seminoma; Testicular Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2012
FDG-PET-positive foreign-body granuloma mimicking residual germinal tumor infiltration.
    Clinical nuclear medicine, 2012, Volume: 37, Issue:8

    Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Male; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Testicular Neoplasms; Tomography, X-Ray Computed

2012
[Relapse of primary testicular non-Hodgkin's lymphoma detected by 18F-FDG-PET/CT].
    Recenti progressi in medicina, 2012, Volume: 103, Issue:11

    Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed

2012
Huge testicular lymphoma on 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography-computed tomography.
    The American journal of the medical sciences, 2013, Volume: 345, Issue:6

    Topics: Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Testicular Neoplasms; Tomography, X-Ray Computed

2013
A PET study on the characterization of partially reversible radiogenic lower motor neurone disease.
    Spinal cord, 2002, Volume: 40, Issue:9

    Topics: Adult; Cobalt Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Motor Neuron Disease; Radioisotope Teletherapy; Radiopharmaceuticals; Recovery of Function; Seminoma; Sodium Channels; Testicular Neoplasms; Tomography, Emission-Computed

2002
Diagnosis of a contralateral second testicular carcinoma by F18-FDG PET.
    Onkologie, 2003, Volume: 26, Issue:2

    Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Second Primary; Testicular Neoplasms; Testis; Tomography, Emission-Computed

2003
Use of FDG-PET in testicular tumours.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2003, Volume: 15, Issue:3

    Topics: Fluorodeoxyglucose F18; Germinoma; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Radiopharmaceuticals; Testicular Neoplasms; Tomography, Emission-Computed

2003
PET imaging of Sertoli cell tumor in androgen insensitivity syndrome.
    Clinical nuclear medicine, 2003, Volume: 28, Issue:9

    Topics: Aged; Androgen-Insensitivity Syndrome; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Radiopharmaceuticals; Sertoli Cell Tumor; Testicular Neoplasms; Tomography, Emission-Computed

2003
[The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
    Voprosy onkologii, 2003, Volume: 49, Issue:5

    Topics: Brain Neoplasms; Breast Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Medical Oncology; Neoplasms; Outcome Assessment, Health Care; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed

2003
[Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2004, Volume: 176, Issue:1

    Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Fluorodeoxyglucose F18; Follow-Up Studies; Germany; Germinoma; Humans; Karnofsky Performance Status; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Patient Selection; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed

2004
2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Mar-15, Volume: 22, Issue:6

    Topics: Austria; Clinical Trials as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Germany; Humans; Male; Neoplasm, Residual; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed

2004
Diffuse splenic metastases from seminoma visualized on FDG PET.
    AJR. American journal of roentgenology, 2004, Volume: 183, Issue:2

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Splenic Neoplasms; Testicular Neoplasms; Tomography, Emission-Computed

2004
Melanoma metastasis to the testis demonstrated with FDG PET/CT.
    Clinical nuclear medicine, 2004, Volume: 29, Issue:12

    Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Subtraction Technique; Testicular Neoplasms; Tomography, X-Ray Computed

2004
[Positron emission tomography in oncourology].
    Vestnik Rossiiskoi akademii meditsinskikh nauk, 2005, Issue:9

    Topics: Adolescent; Adult; Aged; Carcinoma, Embryonal; Carcinoma, Renal Cell; Choriocarcinoma; Data Interpretation, Statistical; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Testis

2005
Recurrence of lymphoma presenting as asymmetrically increased testicular activity on FDG-PET/CT.
    Seminars in nuclear medicine, 2006, Volume: 36, Issue:1

    Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed

2006
Republication of SEMPET trial data?
    European journal of radiology, 2006, Volume: 58, Issue:2

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiographic Image Enhancement; Radiography, Abdominal; Radiopharmaceuticals; Seminoma; Testicular Neoplasms

2006
[A case of primary and solitary bone metastasis of testicular seminoma after orchiectomy].
    Hinyokika kiyo. Acta urologica Japonica, 2005, Volume: 51, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Etoposide; Fluorodeoxyglucose F18; Humans; Male; Orchiectomy; Peplomycin; Positron-Emission Tomography; Seminoma; Testicular Neoplasms

2005
Anti-Ma2-associated encephalitis with normal FDG-PET: a case of pseudo-Whipple's disease.
    Nature clinical practice. Neurology, 2006, Volume: 2, Issue:10

    Topics: Adult; Antigens, Neoplasm; Brain; Brain Injuries; Diagnosis, Differential; Diagnostic Errors; Encephalitis; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Nerve Tissue Proteins; Paraneoplastic Syndromes; Positron-Emission Tomography; Seizures; Testicular Neoplasms; Whipple Disease

2006
A unique presentation of appendicitis: F-18 FDG PET/CT.
    Clinical nuclear medicine, 2006, Volume: 31, Issue:11

    Topics: Adult; Appendicitis; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Testicular Neoplasms; Tomography, X-Ray Computed

2006
Unexpected finding of elevated glucose uptake in fibrous dysplasia mimicking malignancy: contradicting metabolism and morphology in combined PET/CT.
    European radiology, 2007, Volume: 17, Issue:7

    Topics: Adult; Blood Glucose; Carcinoma, Embryonal; Combined Modality Therapy; Diagnosis, Differential; Femoral Neoplasms; Fibrous Dysplasia, Polyostotic; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed

2007
Serendipitous detection of testicular seminoma on F-18 FDG positron tomography.
    Clinical nuclear medicine, 2007, Volume: 32, Issue:3

    Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed

2007
[2006 technology monitoring report: clinical practice guideline: use of FDG-PET in kidney, prostate, testis and bladder cancers].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2007, Volume: 17, Issue:2

    Topics: Fluorodeoxyglucose F18; France; Humans; Image Processing, Computer-Assisted; Kidney Neoplasms; Male; Medical Laboratory Science; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Urinary Bladder Neoplasms

2007
Increased pulmonary FDG uptake in bleomycin-associated pneumonitis.
    Onkologie, 2007, Volume: 30, Issue:6

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonia; Positron-Emission Tomography; Seminoma; Testicular Neoplasms; Testis; Tomography, X-Ray Computed

2007
A pitfall of 18-fluorodeoxyglucose-PET in a patient with a tattoo.
    The Lancet. Oncology, 2007, Volume: 8, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Ink; Lymph Nodes; Lymphatic Metastasis; Male; Orchiectomy; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Tattooing; Teratoma; Testicular Neoplasms; Tomography, X-Ray Computed

2007
Imaging metastatic testicular germ cell tumours with 18FDG positron emission tomography: prospects for detection and management.
    European journal of nuclear medicine, 1995, Volume: 22, Issue:6

    Topics: Abdominal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Seminoma; Teratoma; Testicular Neoplasms; Tomography, Emission-Computed

1995
[Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results].
    Der Urologe. Ausg. A, 1995, Volume: 34, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Carcinoma, Renal Cell; Combined Modality Therapy; Deoxyglucose; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Postoperative Complications; Salvage Therapy; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urogenital Neoplasms

1995
FDG-PET screening for cerebral metastases in patients with suspected malignancy.
    Nuclear medicine communications, 1996, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Breast Neoplasms; Child; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Retrospective Studies; Sarcoma; Testicular Neoplasms; Tomography, Emission-Computed

1996
FDG-PET evaluation of retroperitoneal metastases of testicular cancer before and after chemotherapy.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:1

    Topics: Adult; Carcinoma, Embryonal; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Retroperitoneal Neoplasms; Testicular Neoplasms; Tomography, Emission-Computed

1997
FDG PET for detection and therapy control of metastatic germ cell tumor.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Germinoma; Humans; Male; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed

1998
Seminoma and sarcoidosis: a cause for false positive mediastinal uptake in PET?
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:8

    Topics: False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Mediastinum; Sarcoidosis; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed

1998
[Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
    Der Urologe. Ausg. A, 1998, Volume: 37, Issue:6

    Topics: Adult; Biomarkers, Tumor; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed

1998
PET and PLAP in suspected testicular cancer relapse: beware sarcoidosis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:10

    Topics: Adult; Alkaline Phosphatase; Diagnosis, Differential; Fluorodeoxyglucose F18; GPI-Linked Proteins; Humans; Immunohistochemistry; Isoenzymes; Lung Neoplasms; Lymphatic Diseases; Male; Mediastinum; Radiopharmaceuticals; Sarcoidosis; Testicular Neoplasms; Tomography, Emission-Computed

2001
Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors.
    Urologia internationalis, 2002, Volume: 68, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorodeoxyglucose F18; Germinoma; Humans; Male; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed

2002
The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.
    BJU international, 2002, Volume: 89, Issue:6

    Topics: Adolescent; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Germinoma; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Testicular Neoplasms; Tomography, Emission-Computed

2002
18F-fluoro-2-deoxyglucose-positron emission tomography in the evaluation of nonseminomatous germ cell tumours at relapse.
    BJU international, 2002, Volume: 89, Issue:9

    Topics: Adolescent; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Germinoma; Humans; Male; Neoplasm Recurrence, Local; Orchiectomy; Radiography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Testicular Neoplasms; Tomography, Emission-Computed

2002
[Positron emission tomography in the investigation of malignant testicular tumors].
    Orvosi hetilap, 2002, May-26, Volume: 143, Issue:21 Suppl 3

    Topics: Adolescent; Adult; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Testicular Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed

2002